Pseudomonas aeruginosa infections.
D000818:Animals; D000907:Antibodies, Bacterial; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000382:microbiology; D001847:Bone Diseases / Q000382:microbiology; D002056:Burns / Q000150:complications; D002228:Carbenicillin / Q000627:therapeutic use; D002353:Carrier State; D003091:Colistin / Q000627:therapeutic use; D003428:Cross Infection / Q000453:epidemiology; D003550:Cystic Fibrosis / Q000150:complications; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007938:Leukemia / Q000150:complications; D008171:Lung Diseases / Q000150:complications; D011014:Pneumonia / Q000382:microbiology; D011113:Polymyxins / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D011550:Pseudomonas aeruginosa / Q000145:classification / Q000276:immunology; D012138:Respiratory Therapy / Q000009:adverse effects; D012874:Skin Diseases, Infectious / Q000382:microbiology; D013530:Surgical Wound Infection / Q000382:microbiology; D014184:Transplantation, Homologous
D000907:Antibodies, Bacterial; D000970:Antineoplastic Agents; D005839:Gentamicins; D011113:Polymyxins; D002228:Carbenicillin; D003091:Colistin